|
|
||||||||
REVIEW |
CIHR Group in Matrix Dynamics, Faculty of Dentistry, University of Toronto, 124 Edward Street, Toronto, ON M5G 1G6, Canada
* corresponding author, ron.zohar{at}utoronto.ca
Protection of mucosal tissues of the oral cavity, intestines, respiratory tract, and urogenital tract from the constant challenge of pathogens is achieved by the combined barrier function of the lining epithelia and specialized immune cells. Recent studies have indicated that osteopontin (OPN) has a pivotal role in the development of immune responses and in the tissue destruction and the subsequent repair processes associated with inflammatory diseases. While expression of OPN is increased in immune cellsincluding neutrophils, macrophages, T- and B-lymphocytesand in epithelial, endothelial, and fibroblastic cells of inflamed tissues, deciphering the specific functions of OPN has been difficult. In part, this is due to the broad range of biological activities of OPN that are mediated by multiple receptors which recognize several signaling motifs whose activities are influenced by post-translational modifications and proteolytic processing of OPN. Understanding the role of OPN in mucosal inflammation is further complicated by its contributions to the barrier function of the lining epithelia and the complexity of the specialized mucosal immune system. In an attempt to provide some insights into the involvement of OPN in mucosal diseases, this review summarizes current knowledge of the biological activities of OPN involved in the development of inflammatory responses and in wound healing, and indicates how these activities may affect the protection of mucosal tissues.
KEY WORDS: osteopontin mucosa immunity
This article has been cited by other articles:
![]() |
M. Riedl, G. Vila, C. Maier, A. Handisurya, S. Shakeri-Manesch, G. Prager, O. Wagner, A. Kautzky-Willer, B. Ludvik, M. Clodi, et al. Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2307 - 2312. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lenga, A. Koh, A. S. Perera, C. A. McCulloch, J. Sodek, and R. Zohar Osteopontin Expression Is Required for Myofibroblast Differentiation Circ. Res., February 15, 2008; 102(3): 319 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. X. Wang, Y. Shi, and D. T. Denhardt Osteopontin regulates hindlimb-unloading-induced lymphoid organ atrophy and weight loss by modulating corticosteroid production PNAS, September 11, 2007; 104(37): 14777 - 14782. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Christensen, C. C. Kazanecki, T. E. Petersen, S. R. Rittling, D. T. Denhardt, and E. S. Sorensen Cell Type-specific Post-translational Modifications of Mouse Osteopontin Are Associated with Different Adhesive Properties J. Biol. Chem., July 6, 2007; 282(27): 19463 - 19472. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Kaartinen, M. Murshed, G. Karsenty, and M. D. McKee Osteopontin Upregulation and Polymerization by Transglutaminase 2 in Calcified Arteries of Matrix Gla Protein-deficient Mice J. Histochem. Cytochem., April 1, 2007; 55(4): 375 - 386. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |